Impact and Assessment of the European In Vitro Diagnostic Regulations

25 April 2017 4 Greenfield Crescent, Edgbaston, Birmingham B15 3BE

The final text of the new regulations has now been published, so now is the time to gain a detailed understanding of the European compliance landscape which is going to dictate business strategy for the next 20 years.

Medilink West Midlands, in conjunction with Acclaim Biomedical Consulting, is offering a one-day one day workshop exploring the new European Regulations for In Vitro Diagnostics. With over 20 years' experience in medical devices, Acclaim Biomedical Consulting are best placed to support and advise on the regulatory changes and the impact these will have on existing practice.

Course content and key topics

  • Risk-based product classification
  • Conformity assessment
  • Clinical evaluation
  • Obligations of economic operators.

Learning objectives

This course aims to provide delegates with the insight and tools required to plan and implement an organisational strategy for continued access to the European markets. The course will review critical elements of the new regulations in great depth and will run as a full day, interactive course.

From this workshop, you will take away our specially made checklist, that will assist you with making sure that your organisation is working in line with the new Regulations

Who should attend?

The course is designed for business leaders with a good working knowledge of the current regulatory requirements

Delegate fees

  • Early bird fee: register before Friday 14 April to take advantage of a 10% discount
  • Members' fee: £150
  • Non-members' fee: £190

Lunch and refreshments will be provided. For more information regarding the course and booking, please contact Vanessa Bailey on vanessab@medilinkwm.co.uk or telephone 0121 452 5630.